GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Enhabit Inc (STU:X34) » Definitions » EV-to-EBITDA

Enhabit (STU:X34) EV-to-EBITDA : -16.48 (As of May. 31, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Enhabit EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Enhabit's enterprise value is €937.0 Mil. Enhabit's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was €-56.9 Mil. Therefore, Enhabit's EV-to-EBITDA for today is -16.48.

The historical rank and industry rank for Enhabit's EV-to-EBITDA or its related term are showing as below:

STU:X34' s EV-to-EBITDA Range Over the Past 10 Years
Min: -72.7   Med: -10.35   Max: 2181.98
Current: -16.76

During the past 6 years, the highest EV-to-EBITDA of Enhabit was 2181.98. The lowest was -72.70. And the median was -10.35.

STU:X34's EV-to-EBITDA is ranked worse than
100% of 500 companies
in the Healthcare Providers & Services industry
Industry Median: 12.075 vs STU:X34: -16.76

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-31), Enhabit's stock price is €9.00. Enhabit's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was €-2.541. Therefore, Enhabit's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Enhabit EV-to-EBITDA Historical Data

The historical data trend for Enhabit's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enhabit EV-to-EBITDA Chart

Enhabit Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial - - 57.57 -68.65 -11.54

Enhabit Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -66.69 15.38 -25.58 -11.54 -15.59

Competitive Comparison of Enhabit's EV-to-EBITDA

For the Medical Care Facilities subindustry, Enhabit's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enhabit's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Enhabit's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Enhabit's EV-to-EBITDA falls into.


;
;

Enhabit EV-to-EBITDA Calculation

Enhabit's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=936.963/-56.86
=-16.48

Enhabit's current Enterprise Value is €937.0 Mil.
Enhabit's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-56.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enhabit  (STU:X34) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Enhabit's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=9.00/-2.541
=At Loss

Enhabit's share price for today is €9.00.
Enhabit's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.541.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Enhabit EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Enhabit's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Enhabit Business Description

Traded in Other Exchanges
Address
6688 N. Central Expressway, Suite 1300, Dallas, TX, USA, 75206
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.

Enhabit Headlines

No Headlines